A Large Size Chimeric Highly Immunogenic Peptide Presents Multistage Plasmodium Antigens as a Vaccine Candidate System against Malaria-Reference-Cited by-同舟云学术

A Large Size Chimeric Highly Immunogenic Peptide Presents Multistage Plasmodium Antigens as a Vaccine Candidate System against Malaria

Published:2017-11-01 Issue:11 Volume:22 Page:1837
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Lozano José,Varela Yahson,Silva Yolanda,Ardila Karen,Forero Martha,Guasca Laura,Guerrero Yuly,Bermudez Adriana,Alba Patricia,Vanegas Magnolia,Patarroyo Manuel

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/22/11/1837/pdf

Reference28 articles.

1. WHO Global Malaria Programme,2017

2. Development of a metabolically active, non-replicating sporozoite vaccine to preventPlasmodium falciparummalaria

3. Induction of protective immunity against experimental infection with malaria using synthetic peptides

4. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand

5. Emerging Rules for Subunit-Based, Multiantigenic, Multistage Chemically Synthesized Vaccines

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural Plasmodium falciparum Infection Stimulates Human Antibodies to MSP1 Epitopes Identified in Mice Infection Models upon Non-Natural Modified Peptidomimetic Vaccination;Molecules;2023-03-10

2. A reverse vaccinology approach on transmembrane carbonic anhydrases from Plasmodium species as vaccine candidates for malaria prevention;Malaria Journal;2022-06-15

3. Synthetic Evaluation of Standard and Microwave-Assisted Solid Phase Peptide Synthesis of a Long Chimeric Peptide Derived from Four Plasmodium falciparum Proteins;Molecules;2018-11-05

4. Improving the Breadth of the Host’s Immune Response to Lassa Virus;Pathogens;2018-10-28